VIANI, PAOLA
VIANI, PAOLA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
HDAC6 and HDAC8 combined targeting to counteract Glioblastoma Multiforme progression and treatment resistance
2026 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
Dissecting the Role of HDAC6 and HDAC8 in zebrafish
2026 A. Pistocchi, S. Carbone, G. Galassi, A. Marozzi, P. Viani, A. Pezzotta, L. Brioschi
HDAC6 and HDAC8 combined targeting to counteract Glioblastoma Multiforme progression and treatment resistance
2026 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, E. Villa, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M.C. Mione, L. Mollica, A. Pistocchi, P. Viani
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2026 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2026 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, S. Albadri, M.C. Mione, L. Mollica, P. Viani, A. Pistocchi
HDAC8 AND HDAC6 COMBINED INHIBITION: A NEW FRONTIER IN GLIOBLASTOMA TREATMENT
2025 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, D. Giana, A. Pezzotta, A. Marozzi, G. Carullo, L. Sicuro, L. Mollica, L. Bello, G. Campiani, P. Viani, M.C. Mione, A. Pistocchi
HDAC8 and HDAC6 combined inhibition: a new frontier in glioblastoma treatment
2025 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Pezzotta, A. Marozzi, G. Carullo, L. Sicuro, L. Mollica, L. Bello, G. Campiani, P. Viani, M. Caterina Mione, A. Pistocchi
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2025 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
HDAC6 and HDAC8 inhibition enhances the efficacy of Temozolomide by rewiring sphingolipid metabolism and glioma cell fate
2025 I. Tagliabue, L. Brioschi, G. Galassi, S. Carbone, A. Pezzotta, A. Marozzi, L. Mollica, L. Sicuro, L. Bello, G. Campiani, G. Carullo, M. Caterina Mione, A. Pistocchi, P. Viani
HDAC6 and HDAC8 orchestrate sphingolipid metabolic reprogramming to regulate glioma cell fate
2025 I. Tagliabue, L. Brioschi, G. Galassi, S. Carbone, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, L. Mollica, M.C. Mione, A. Pistocchi, P. Viani
Sphingosine 1-Phosphate Stimulates ER to Golgi Ceramide Traffic to Promote Survival in T98G Glioma Cells
2024 P. Giussani, L. Brioschi, E. Gjoni, E. Riccitelli, P. Viani
Hedgehog and HDAC6 in cancers: dissection of dysregulated biological mechanisms and potential therapeutic treatments
2024 A. Pezzotta, L. Brioschi, S. Carbone, G. Galassi, L. Sicuro, M. Alcalay, G. Carullo, G. Campiani, L. Mollica, A. Marozzi, M. Mione, P. Viani, A. Pistocchi
Combined Inhibition of Hedgehog and HDAC6: In Vitro and In Vivo Studies Reveal a New Role for Lysosomal Stress in Reducing Glioblastoma Cell Viability
2023 A. Pezzotta, L. Brioschi, S. Carbone, B. Mazzoleni, V. Bontempi, F. Monastra, L. Mauri, A. Marozzi, M. Mione, A. Pistocchi, P. Viani
Galactocerebrosidase deficiency induces an increase in lactosylceramide content: A new hallmark of Krabbe disease?
2022 N. Papini, C. Giallanza, L. Brioschi, F.R. Ranieri, P. Giussani, L. Mauri, M.G. Ciampa, P. Viani, C. Tringali
Secreted miR‐153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer
2022 G. Bertoli, A. Panio, C. Cava, F. Gallivanone, M. Alini, G. Strano, F. Molfino, L. Brioschi, P. Viani, D. Porro
Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors
2021 S. Pucci, F. Fasoli, M. Moretti, R. Benfante, S. Di Lascio, P. Viani, A. Daga, T.J. Gordon, M. Mcintosh, M. Zoli, F. Clementi, C. Gotti
Behavioural and pharmacological profiles of zebrafish administrated pyrrolidinyl benzodioxanes and prolinol aryl ethers with high affinity for heteromeric nicotinic acetylcholine receptors
2020 D. Braida, L. Ponzoni, M. Moretti, P. Viani, M. Pallavicini, C. Bolchi, R. Appiani, F. Bavo, C. Gotti, M. Sala
Modifications at C(5) of 2-(2-Pyrrolidinyl)-Substituted 1,4-Benzodioxane Elicit Potent α4β2 Nicotinic Acetylcholine Receptor Partial Agonism with High Selectivity over the α3β4 Subtype
2020 F. Bavo, M. Pallavicini, C. Gotti, R. Appiani, M. Moretti, S.F. Colombo, S. Pucci, P. Viani, R. Budriesi, M. Renzi, S. Fucile, C. Bolchi
Persistent cognitive and affective alterations at late withdrawal stages after long-term intermittent exposure to tobacco smoke or electronic cigarette vapour : Behavioural changes and their neurochemical correlates
2020 L. Ponzoni, D. Braida, L. Carboni, M. Moretti, P. Viani, F. Clementi, M. Zoli, C. Gotti, M. Sala
Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure
2019 M. Lombardi, R. Parolisi, F. Scaroni, E. Bonfanti, A. Gualerzi, M. Gabrielli, N. Kerlero de Rosbo, A. Uccelli, P. Giussani, P. Viani, C. Garlanda, M.P. Abbracchio, L. Chaabane, A. Buffo, M. Fumagalli, C. Verderio